148 related articles for article (PubMed ID: 37316860)
21. Glucocorticoid-induced degradation of glycogen synthase kinase-3 protein is triggered by serum- and glucocorticoid-induced protein kinase and Akt signaling and controls beta-catenin dynamics and tight junction formation in mammary epithelial tumor cells.
Failor KL; Desyatnikov Y; Finger LA; Firestone GL
Mol Endocrinol; 2007 Oct; 21(10):2403-15. PubMed ID: 17595317
[TBL] [Abstract][Full Text] [Related]
22. CG0009, a novel glycogen synthase kinase 3 inhibitor, induces cell death through cyclin D1 depletion in breast cancer cells.
Kim HM; Kim CS; Lee JH; Jang SJ; Hwang JJ; Ro S; Choi J
PLoS One; 2013; 8(4):e60383. PubMed ID: 23565238
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of GSK3 phosphorylation of beta-catenin via phosphorylated PPPSPXS motifs of Wnt coreceptor LRP6.
Wu G; Huang H; Garcia Abreu J; He X
PLoS One; 2009; 4(3):e4926. PubMed ID: 19293931
[TBL] [Abstract][Full Text] [Related]
24. Helicobacter pylori VacA-induced inhibition of GSK3 through the PI3K/Akt signaling pathway.
Nakayama M; Hisatsune J; Yamasaki E; Isomoto H; Kurazono H; Hatakeyama M; Azuma T; Yamaoka Y; Yahiro K; Moss J; Hirayama T
J Biol Chem; 2009 Jan; 284(3):1612-9. PubMed ID: 18996844
[TBL] [Abstract][Full Text] [Related]
25. Regulation of Akt mRNA and protein levels by glycogen synthase kinase-3beta in adrenal chromaffin cells: effects of LiCl and SB216763.
Nemoto T; Kanai T; Yanagita T; Satoh S; Maruta T; Yoshikawa N; Kobayashi H; Wada A
Eur J Pharmacol; 2008 May; 586(1-3):82-9. PubMed ID: 18395711
[TBL] [Abstract][Full Text] [Related]
26. Relative resistance of Cdk5-phosphorylated CRMP2 to dephosphorylation.
Cole AR; Soutar MP; Rembutsu M; van Aalten L; Hastie CJ; McLauchlan H; Peggie M; Balastik M; Lu KP; Sutherland C
J Biol Chem; 2008 Jun; 283(26):18227-37. PubMed ID: 18460467
[TBL] [Abstract][Full Text] [Related]
27. Elucidation of the GSK3α Structure Informs the Design of Novel, Paralog-Selective Inhibitors.
Amaral B; Capacci A; Anderson T; Tezer C; Bajrami B; Lulla M; Lucas B; Chodaparambil JV; Marcotte D; Kumar PR; Murugan P; Spilker K; Cullivan M; Wang T; Peterson AC; Enyedy I; Ma B; Chen T; Yousaf Z; Calhoun M; Golonzhka O; Dillon GM; Koirala S
ACS Chem Neurosci; 2023 Mar; 14(6):1080-1094. PubMed ID: 36812145
[TBL] [Abstract][Full Text] [Related]
28. Localized changes to glycogen synthase kinase-3 and collapsin response mediator protein-2 in the Huntington's disease affected brain.
Lim NK; Hung LW; Pang TY; Mclean CA; Liddell JR; Hilton JB; Li QX; White AR; Hannan AJ; Crouch PJ
Hum Mol Genet; 2014 Aug; 23(15):4051-63. PubMed ID: 24634145
[TBL] [Abstract][Full Text] [Related]
29. Glycogen synthase kinase-3 (GSK3) controls deoxyglucose-induced mitochondrial biogenesis in human neuroblastoma SH-SY5Y cells.
Ngamsiri P; Watcharasit P; Satayavivad J
Mitochondrion; 2014 Jan; 14(1):54-63. PubMed ID: 24316184
[TBL] [Abstract][Full Text] [Related]
30. Glycogen Synthase Kinase 3 (GSK3): Its Role and Inhibitors.
Wadhwa P; Jain P; Jadhav HR
Curr Top Med Chem; 2020; 20(17):1522-1534. PubMed ID: 32416693
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of glycogen synthase kinase 3beta prevents peroxide-induced collapse of mitochondrial membrane potential in rat ventricular myocytes.
Förster K; Richter H; Alexeyev MF; Rosskopf D; Felix SB; Krieg T
Clin Exp Pharmacol Physiol; 2010 Jul; 37(7):684-8. PubMed ID: 20337662
[TBL] [Abstract][Full Text] [Related]
32. Glycogen synthase kinase-3β is a functional modulator of serotonin-1B receptors.
Chen L; Zhou W; Chen PC; Gaisina I; Yang S; Li X
Mol Pharmacol; 2011 Jun; 79(6):974-86. PubMed ID: 21372171
[TBL] [Abstract][Full Text] [Related]
33. A GSK3-binding peptide from FRAT1 selectively inhibits the GSK3-catalysed phosphorylation of axin and beta-catenin.
Thomas GM; Frame S; Goedert M; Nathke I; Polakis P; Cohen P
FEBS Lett; 1999 Sep; 458(2):247-51. PubMed ID: 10481074
[TBL] [Abstract][Full Text] [Related]
34. Analysis of Glycogen Synthase Kinase Inhibitors That Regulate Cytochrome P450 Expression in Primary Human Hepatocytes by Activation of β-Catenin, Aryl Hydrocarbon Receptor and Pregnane X Receptor Signaling.
Briolotti P; Chaloin L; Balaguer P; Da Silva F; Tománková V; Pascussi JM; Duret C; Fabre JM; Ramos J; Klieber S; Maurel P; Daujat-Chavanieu M; Gerbal-Chaloin S
Toxicol Sci; 2015 Nov; 148(1):261-75. PubMed ID: 26259606
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of glycogen synthase kinase-3 alleviates Tcf3 repression of the pluripotency network and increases embryonic stem cell resistance to differentiation.
Wray J; Kalkan T; Gomez-Lopez S; Eckardt D; Cook A; Kemler R; Smith A
Nat Cell Biol; 2011 Jun; 13(7):838-45. PubMed ID: 21685889
[TBL] [Abstract][Full Text] [Related]
36. Cyclin D1 over-expression correlates with beta-catenin activation, but not with H-ras mutations, and phosphorylation of Akt, GSK3 beta and ERK1/2 in mouse hepatic carcinogenesis.
Gotoh J; Obata M; Yoshie M; Kasai S; Ogawa K
Carcinogenesis; 2003 Mar; 24(3):435-42. PubMed ID: 12663502
[TBL] [Abstract][Full Text] [Related]
37. Selective GSK3β Inhibition Mediates an Nrf2-Independent Anti-inflammatory Microglial Response.
Yousef MH; Salama M; El-Fawal HAN; Abdelnaser A
Mol Neurobiol; 2022 Sep; 59(9):5591-5611. PubMed ID: 35739410
[TBL] [Abstract][Full Text] [Related]
38. Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle.
Dokken BB; Sloniger JA; Henriksen EJ
Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1188-94. PubMed ID: 15671078
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice.
Xia YX; Lu L; Wu ZS; Pu LY; Sun BC; Wang XH
Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):278-84. PubMed ID: 22672822
[TBL] [Abstract][Full Text] [Related]
40. Leptin-induced epithelial-mesenchymal transition in breast cancer cells requires β-catenin activation via Akt/GSK3- and MTA1/Wnt1 protein-dependent pathways.
Yan D; Avtanski D; Saxena NK; Sharma D
J Biol Chem; 2012 Mar; 287(11):8598-612. PubMed ID: 22270359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
